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Abstract: A novel class of N-Fmoc-protected amino alkyl thiocy-
anates/selenocyanates has been prepared by thiocyanation/seleno-
cyanation of the corresponding alkyl iodides. These thiocyanates/
selenocyanates undergo a facile [2+3]-cycloaddition reaction with
sodium azide to afford novel N-Fmoc amino alkyl S/Se-linked tetra-
zoles.
Key words: amino acid derivatives, thiocyanates, selenocyanates,
[2+3] cycloaddition, S/Se-linked tetrazoles
Modification of the native structure of amino acids by in-
serting heterocycles such as tetrazoles, triazoles, thiazoles
and isoxazoles through selective carboxy group transfor-
mation has been of considerable interest in biochemistry,
enzymology and pharmacology.1 In particular, tetrazoles
have been extensively studied in recent years due to their
ability to act as a metabolically stable surrogate for the
carboxy group,2 and hence have been used in designing
potential anti-inflammatory, central nervous stimulant
and hypertensive agents. They are also employed as cis-
peptide bond mimics and have found numerous applica-
tions as catalysts in asymmetric synthesis.3 Specifically,
5-S-linked tetrazoles are an important class of compounds
known for their biological and chemical potency. Due to
the presence of the alkylthio linkage, they show increased
acidity and solubility which makes them powerful activa-
tors for DNA and RNA syntheses.4 On similar lines, 5-Se-
linked tetrazoles would also represent a useful subclass
which has scarcely been addressed in the literature. The
recent surge in selenium chemistry,5 and the discovery of
several selenoproteins, prompted us to work on selenium
derivatization of amino acids, such as the 5-Se-linked tet-
razoles.
The most feasible and practical routes for the synthesis of
tetrazoles, in general, involve either reaction of a substi-
tuted halide with 1H-tetrazole or a [2+3]-cycloaddition re-
action of a nitrile with an azide ion.1a,6 Demko and
Sharpless have reported an efficient protocol for the syn-
thesis of 5-substituted amino alkyl tetrazoles by the reac-
tion of Na-Z amino nitriles with sodium azide and zinc
bromide, followed by removal of the Z group; however,
the removal of the protecting group was a challenging
task.1a–c In this regard, our use of the Fmoc group for Na-
protection led to a simple isolation of the free amino tetra-
zoles.7 A literature survey on S/Se-linked tetrazoles result-
ed in a handful of reports. Dondoni and co-workers
synthesized S-tetrazoles bearing C-glycosyl a-amino ac-
ids wherein sugar-derived C-alkyl azides were first treat-
ed with tosyl cyanide at 100 °C, followed by replacement
of the tosyl group with cysteine thiol.8 Jursic’s group re-
ported the synthesis of 5-alkyl- and 5-aryl-S-linked tetra-
zoles from the corresponding thiocyanates.9 Yildirir and
co-workers prepared Se-linked tetrazoles by a reaction of
aromatic selenocyanates with sodium azide.10 Though tet-
razole derivatives of amino acids have been prepared and
employed in varied applications including organic cataly-
sis,3 the chemistry has not been extended to the prepara-
tion of S/Se-linked tetrazole derivatives from amino acids.
Due to the widespread application of S/Se-linked tetra-
zolyl compounds, we reasoned that insertion of such moi-
eties in place of the carboxy group of an amino acid would
generate novel precursors for the synthesis of peptidic
drug candidates, as well as for catalyst applications.11 In
the present study, the synthesis of S/Se-linked tetrazoles
by a [2+3]-cycloaddition reaction of N-protected amino
alkyl thiocyanates/selenocyanates with sodium azide is
described.
With our previous experience in the synthesis of Na-Fmoc
amino tetrazoles from the respective nitriles, we envis-
aged that Na-Fmoc amino alkyl thiocyanates/selenocyan-
ates would be the ideal intermediates for accessing S/Se-
linked tetrazoles. Thiocyanates/selenocyanates are versa-
tile synthetic intermediates and, owing to their electro-
philic nature, they can be engaged as effective
dipolarophilic partners of an azide ion. Thiocyanato com-
pounds themselves have been used for the preparation of
a few pharmaceuticals.12 They can also serve as precur-
sors for a plethora of diverse reactions including the syn-
thesis of thio-heterocycles, thiophenols, thiocarbamates,
dithiourethanes and sulfonyl cyanides.13 Likewise, organ-
ic selenocyanates are also of interest due to their enhanced
cancer chemopreventive activities and utility as starting
materials for the synthesis of selenium-containing hetero-
cycles, diselenides and selenoketones.14
Several methods are available for the preparation of thio-
cyanates; most of these involve substitution of a halide
with thiocyanic acid or its salt. Some of the other notable
protocols make use of thiocyanating agents such as 1-n-
butyl-3-methylimidazolium thiocyanate ([bmim]SCN),15
direct nucleophilic substitution of alcohols with the thio-
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cyanate anion16 or the Mitsunobu reagent system (Ph3P–
DEAD–NH4SCN).17 Similarly, selenocyanates are ac-
cessed by nucleophilic substitution of halides with the se-
lenocyanate ion.18 Kachanov’s group reported a one-pot
synthesis of selenocyanates using triselenium dicyanide
as the selenocyanating agent.19
Our interest in designing peptidomimetics and unnatural
amino acid derivatives has led to several useful amino
acid derived synthons including isocyanates of Na-Fmoc-
protected amino acids,20 N-urethane-protected amino
alkyl isothiocyanates,21 Na-Fmoc amino alkyl
formamides22 and N-Fmoc b-amino alkyl isonitriles.23
Though thiocyanate and selenocyanate derivatives have
prevailed in various other classes of compounds including
carbohydrates,24 to the best of our knowledge, N-protect-
ed amino alkyl thiocyanates and selenocyanates are yet to
be reported.
In the present work, the Fmoc group was selected for N-
protection25 and potassium thiocyanate as the thiocyanat-
ing agent.26 The essential precursors, N-Fmoc amino alkyl
iodides 1a–h (Scheme 1), were prepared via a reported
protocol.27 In brief, N-Fmoc amino acids were reduced to
the corresponding b-amino alcohols28 and then subjected
to the Mitsunobu reaction (Ph3P–imidazole–I2).21 In the
next step, a solution of the N-Fmoc amino alkyl iodide 1
was treated with potassium thiocyanate. Either at room
temperature or under reflux, the progress of the reaction
was not satisfactory; however, use of a catalytic amount of
tetrabutylammonium bromide drove the reaction to com-
pletion in a short duration of time. In a typical reaction, a
solution of Fmoc-Phe-y(CH2I) (1c, R = Bn) in tetrahydro-
furan was refluxed along with potassium thiocyanate and
catalytic tetrabutylammonium bromide (Scheme 1). After
completion of the reaction (TLC analysis), a simple work-
up afforded the corresponding thiocyanate 2c in good
yield with a purity of about 91%. HPLC analysis of crude
2c showed a single major peak and no trace of the corre-
sponding isothiocyanate, which otherwise can be formed
due to the ambient nature of the thiocyanate ion, was ob-
served. This was further confirmed by comparing the
HPLC chromatograms of Fmoc-Phg-y(CH2NCS) (pre-
pared according to our previous report21) with Fmoc-Phg-
y(CH2SCN) (2d, R = Ph) now in hand.29
A single recrystallization using tetrahydrofuran–hexane
elevated the purity of the samples to 99% (HPLC analy-
sis). The 13C NMR spectra of these thiocyanates have a
prominent signal around 112 ppm, characteristic of SCN,
while the IR spectra display a CN stretch at around 2135
cm–1.
To demonstrate the generality of this protocol, a series of
N-Fmoc amino alkyl iodides was converted into the corre-
sponding thiocyanates 2a–e, including examples derived
from bifunctional amino acids, resulting in Fmoc-
Cys(Bn)-y(CH2SCN) (2f), Fmoc-Asp(t-Bu)-y(CH2SCN)
(2g) and Fmoc-Lys(Z)-y(CH2SCN) (2h) (Table 1). The
thiocyanates were stable toward long-time storage at
ambient temperature, with no noticeable degradation, as
confirmed by HPLC analysis. Further, the thiocyanate
moiety was also inserted in place of the side-chain hy-
droxy group of serine and homoserine (Figure 1; 2i, 2j).
Figure 1
A similar protocol was also employed for the preparation
of a few N-Fmoc amino alkyl selenocyanates, by reaction
of the corresponding alkyl iodides with potassium seleno-
cyanate (Table 1, 3a–c). The 13C NMR spectrum of 3a has
a characteristic signal at 101.9 ppm and the IR spectrum
shows a CN stretch at 2145 cm–1. The selenocyanate moi-
ety was also inserted in the w-carboxy position of Fmoc-
Glu-OMe (Figure 1, 3d).
Further, treatment of 2i and 3d in a separate set of exper-
iments with diethylamine–dichloromethane (1:1) for 45
minutes afforded the corresponding free amino methyl
esters 4i and 5d in 98% and 95% yield, respectively
(Scheme 2). On the other hand, deprotection of the methyl
ester in 2i and 3d was accomplished following a protocol
reported by Pascal and Sola;30 the free carboxy com-
pounds 6i and 7d were isolated in 85% and 75% yield, re-
spectively (Scheme 2). All of these compounds were
characterized employing mass and NMR spectroscopy.
In the next set of experiments, we undertook the synthesis
of S- and Se-linked tetrazoles. In a typical study, Fmoc-Scheme 1 Synthesis of N-Fmoc-protected amino alkyl thiocya-nates/selenocyanates
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Phe-y(CH2SCN) (2c, R = Bn) was refluxed along with so-
dium azide and zinc bromide in a water–2-propanol sys-
tem (Scheme 3). The reaction was complete in 4.5 hours
(TLC analysis). It is worth mentioning that, compared to
nitriles,7 thiocyanates undergo the cycloaddition reaction
with sodium azide in a shorter duration of time, which can
be attributed to the electron-withdrawing nature of the S
atom. A simple workup afforded the desired S-linked tet-
razole 8c as a solid in 88% yield. The protocol was ex-
tended to the preparation of a series of examples of N-
Fmoc amino alkyl S-linked tetrazoles 8a–h. In a similar
way, Se-linked tetrazoles 9a–c were prepared by a [2+3]-
cycloaddition reaction of the corresponding selenocya-
nates with sodium azide (Scheme 3, Table 2).
Scheme 3 Synthesis of N-Fmoc-protected amino alkyl S/Se-linked
tetrazoles
Further, S-linked tetrazoles were also incorporated in the
side chain of serine and homoserine (Figure 2; 8i, 8j). In
another example, a Se-linked tetrazole was inserted in
place of the w-carboxy group of Fmoc-Glu-OMe
(Figure 2, 9d).
Figure 2
Two S-linked tetrazoles 8a, 8e and a Se-linked tetrazole
9b were treated with diethylamine–dichloromethane (1:1)
and the free amino alkyl S/Se-linked tetrazoles 10a, 10e
and 11b, respectively, were isolated as solids (Figure 3).
The purity of these free amino derivatives was confirmed
by RP-HPLC.31
In summary, the preparation of N-Fmoc amino alkyl thio-
cyanates/selenocyanates by reaction of the corresponding
Table 1 List of the Synthesized Thiocyanates/Selenocyanates 2/3
Entry Yield 
(%)
Mp 
(°C)
[a]D29 
(c 0.2, MeOH)
HRMS: [M + Na]+
calcd (found)
R X
1 2a Me S 92 104–106 +68.0 361.0987 
(361.0981)
2 2b i-Pr S 91 107–108 +38.1 389.1300 
(389.1294)
3 2c Bn S 94 105–107 +28.5 432.1746 
(432.1742)a
4 2d Ph S 91 gum –2.2 418.1589 
(418.1588)a
5 2e -(CH2)3-[Pro] S 82 gum –4.2 387.1143 
(387.1146)
6 2f CH2SBn S 81 gum +4.0 483.1177 
(483.1171)
7 2g CH2COOt-Bu S 71 98–99 –2.4 461.1511 
(461.1516)
8 2h (CH2)4NHZ S 88 106–108 +6.0 547.2379 
(547.2373)a 
9 3a Me Se 89 102–103 +12.3 409.0431 
(409.0438)
10 3b i-Pr Se 88 109–110 +23.5 437.0744 
(437.0750)
11 3c i-Bu Se 86 111–113 +28.3 451.0901 
(451.0908)
a
 [M + NH4]+.
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alkyl iodides with potassium thiocyanate or selenocyanate
in the presence of tetrabutylammonium bromide is report-
ed. The synthetic utility of these thiocyanates/selenocya-
nates has been demonstrated by the preparation of a
hitherto unreported class of 5-substituted S/Se-linked tet-
razoles via a [2+3]-cycloaddition reaction with sodium
azide. Side-chain modification of a few bifunctional ami-
no acids is also reported. Free a-amino alkyl S/Se-linked
tetrazoles were isolated upon removal of the Fmoc group.
Keeping in mind the advantages of tetrazole analogues of
amino acids, the S,Se-linked tetrazole derivatives are also
expected to deliver interesting properties.
Table 2 List of the Synthesized S/Se-Linked Tetrazoles 8/9
Entry Tetrazole Yield (%) Mp (°C) [a]D29 (c 0.2, 
THF)
HRMS: [M + Na]+
calcd (found)
1 8a 92 92–94 –21.0 382.13 (382.05)a,b
2 8b 87 gum +12.0 410.1651 (410.1646)b
3 8c 88 141–142 +9.0 480.1470 (480.1465)
4 8d 88 151–152 +8.4 444.1494 (444.1498)b
5 8e 85 gum –13.5 408.1494 (408.1495)b
6 8f 85 142–143 +16.7 521.1793 (521.1785)c
7 8g 78 78–80 +11.9 504.1681 (504.1686)
8 8h 78 148–150 +18.6 573.2284 (573.2287)b
9 9a 89 136–139 +3.5 430.0782 (430.0790)b
10 9b 86 gum +1.6 480.0915 (480.0923)
11 9c 85 gum +5.6 472.1252 (472.1260)b
a
 ESI-MS.
b
 [M + H]+.
c
 [M + NH4]+.
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All solvents were distilled prior to use and reagents were used as re-
ceived from Sigma-Aldrich. Melting points were determined on a
Büchi model 150 melting point apparatus in open capillaries and are
uncorrected. IR spectra were recorded on a Nicolet Impact 400D
FT-IR spectrometer (KBr pellets, 3 cm–1 resolution). 1H and 13C
NMR spectra were recorded on a Bruker AMX 400 (400 MHz)
spectrometer. High-resolution mass spectra (HRMS) were recorded
on a Micromass Q-Tof mass spectrometer. HPLC analysis was car-
ried out using an Agilent 1100 series G1311A VWD system at
l = 254 nm (flow: 0.5 mL/min, column: C18, 5 mm pore size, 4.6 ×
250 mm).
N-Fmoc Amino Alkyl Thiocyanates/Selenocyanates 2/3; Gener-
al Procedure
To a soln of a N-Fmoc amino alkyl iodide 1 (1 mmol) in THF (15
mL) were added KSCN or KSeCN (1.5 mmol) and TBAB (0.1
mmol), and the mixture was refluxed for about 3 h. After comple-
tion of the reaction (TLC), the solvent was evaporated under re-
duced pressure. The residue was diluted with EtOAc (12 mL); this
solution was washed with H2O (2 × 10 mL) and brine (10 mL), and
dried (anhyd Na2SO4). The solvent was evaporated under reduced
pressure and the residue was recrystallized (EtOAc–hexane) to ob-
tain the product 2/3 as analytically pure material.
(9H-Fluoren-9-yl)methyl (S)-1-Thiocyanatopropan-2-ylcar-
bamate [Fmoc-Ala-y(CH2SCN), 2a]
Yield: 311 mg (92%); white solid; mp 104–106 °C; Rf = 0.3 (n-hex-
ane–EtOAc, 9:1).
IR (KBr): 1713, 2138 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.24 (d, J = 4.8 Hz, 3 H), 3.02–
3.08 (m, 2 H), 3.96 (m, 1 H), 4.11–4.20 (m, 2 H), 4.21 (t, J = 3.0 Hz,
1 H), 4.99 (br, 1 H), 7.21–7.68 (m, 8 H).
13C NMR (100 MHz, CDCl3): d = 19.5, 40.2, 47.7, 52.7, 67.2,
113.0, 120.5, 125.6, 127.6, 128.3, 141.8, 144.2, 155.9.
HRMS: m/z [M + Na]+ calcd for C19H18N2NaO2S: 361.0987; found:
361.0981.
(9H-Fluoren-9-yl)methyl (S)-3-Methyl-1-thiocyanatobutan-2-
ylcarbamate [Fmoc-Val-y(CH2SCN), 2b]
Yield: 333 mg (91%); white solid; mp 107–108 °C; Rf = 0.25 (n-
hexane–EtOAc, 9:1).
IR (KBr): 1701, 2138 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.85 (d, J = 4.8 Hz, 6 H), 1.81 (m,
1 H), 3.05 (d, J = 6.0 Hz, 2 H), 3.55–3.68 (m, 1 H), 4.05–4.22 (m, 3
H), 4.86 (d, J = 6.0 Hz, 1 H), 7.18–7.68 (m, 8 H).
13C NMR (100 MHz, CDCl3): d = 18.6, 19.9, 31.4, 37.7, 47.7, 57.0,
67.1, 113.0, 120.5, 125.5, 127.6, 128.2, 141.8, 144.2, 156.5.
HRMS: m/z [M + Na]+ calcd for C21H22N2NaO2S: 389.1300; found:
389.1294.
(9H-Fluoren-9-yl)methyl (S)-3-Phenyl-1-thiocyanatopropan-2-
ylcarbamate [Fmoc-Phe-y(CH2SCN), 2c]
Yield: 390 mg (94%); white solid; mp 105–107 °C; Rf = 0.35 (n-
hexane–EtOAc, 9:1).
IR (KBr): 1708, 2135 cm–1.
1H NMR (400 MHz, CDCl3): d = 2.74 (d, J = 5.1 Hz, 2 H), 4.07 (d,
J = 5.7 Hz, 2 H), 4.15 (t, J = 5.7 Hz, 1 H), 4.31 (m, 1 H), 4.42 (d,
J = 6.8 Hz, 2 H), 5.35 (d, J = 5.7 Hz, 1 H), 7.16–7.62 (m, 13 H).
13C NMR (100 MHz, CDCl3): d = 33.5, 47.3, 52.3, 53.0, 62.3,
111.9, 120.1, 124.9, 125.1, 127.1, 127.9, 128.1, 129.9, 138.9, 141.4,
143.5, 156.1.
HRMS: m/z [M + NH4]+ calcd for C25H26N3O2S: 432.1746; found:
432.1742.
(9H-Fluoren-9-yl)methyl (S)-1-Phenyl-2-thiocyanatoethylcar-
bamate [Fmoc-Phg-y(CH2SCN), 2d]
Yield: 364 mg (91%); gum; Rf = 0.35 (n-hexane–EtOAc, 9:1).
IR (CH2Cl2): 1703, 2139 cm–1.
1H NMR (400 MHz, CDCl3): d = 3.40 (d, J = 6.0 Hz, 2 H), 4.15 (t,
J = 4.5 Hz, 1 H), 4.21 (m, 1 H), 4.28 (d, J = 3.2 Hz, 2 H), 5.98 (m,
1 H), 7.26–7.77 (m, 13 H).
13C NMR (100 MHz, CDCl3): d = 39.1, 47.2, 55.2, 66.9, 111.6,
124.9, 126.4, 127.1, 127.7, 128.5, 128.7, 129.2, 138.1, 141.3, 143.6,
155.5.
HRMS: m/z [M + NH4]+ calcd for C24H24N3O2S: 418.1589; found:
418.1588.
(9H-Fluoren-9-yl)methyl (S)-2-(Thiocyanatomethyl)pyrroli-
dine-1-carboxylate [Fmoc-Pro-y(CH2SCN), 2e]
Yield: 299 mg (82%); gum; Rf = 0.25 (n-hexane–EtOAc, 9:1).
IR (CH2Cl2): 1712, 2137 cm–1.
1H NMR (400 MHz, CDCl3): d = 2.07 (m, 4 H), 3.35 (m, 2 H), 3.59
(m, 2 H), 3.84 (m, 1 H), 4.15 (t, J = 6.0 Hz, 1 H), 4.28 (d, J = 3.6
Hz, 2 H), 7.26–7.76 (m, 8 H).
13C NMR (100 MHz, CDCl3): d = 20.6, 30.3, 35.0, 47.3, 47.8, 53.6,
67.2, 119.8, 124.2, 125.3, 126.8, 127.4, 141.0, 144.9, 155.6.
HRMS: m/z [M + Na]+ calcd for C21H20N2NaO2S: 387.1143; found:
387.1146.
(9H-Fluoren-9-yl)methyl (S)-1-(Benzylthio)-3-thiocyanatopro-
pan-2-ylcarbamate [Fmoc-Cys(Bn)-y(CH2SCN), 2f]
Yield: 373 mg (81%); gum; Rf = 0.35 (n-hexane–EtOAc, 9:1).
IR (CH2Cl2): 1699, 2138 cm–1.
1H NMR (400 MHz, CDCl3): d = 2.02 (d, J = 6.2 Hz, 2 H), 3.35 (d,
J = 7.2 Hz, 2 H), 3.68 (s, 2 H), 4.12–4.30 (m, 3 H), 4.42 (br, 1 H),
5.32 (br, 1 H), 7.13–7.82 (m, 13 H).
13C NMR (100 MHz, CDCl3): d = 33.9, 36.5, 36.9, 47.1, 50.6, 66.8,
111.9, 125.0, 127.0, 127.4, 127.7, 128.7, 128.8, 130.1, 137.3, 141.3,
143.6, 155.5.
HRMS: m/z [M + Na]+ calcd for C26H24N2NaO2S2: 483.1177;
found: 483.1171.
tert-Butyl (S)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-
4-thiocyanatobutanoate [Fmoc-Asp(t-Bu)-y(CH2SCN), 2g]
Yield: 311 mg (71%); white solid; mp 98–99 °C; Rf = 0.30 (n-hex-
ane–EtOAc, 9:1).
IR (KBr): 1714, 2134 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.29 (s, 9 H), 2.77 (d, J = 6.8 Hz,
2 H), 3.21 (d, J = 6.2 Hz, 2 H), 3.82 (m, 1 H), 4.14 (t, J = 5.6 Hz, 1
H), 4.29 (d,  J = 4.4 Hz, 2 H), 5.62 (br, 1 H), 7.29–7.38 (m, 8 H).
Figure 3
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13C NMR (100 MHz, CDCl3): d = 26.5, 37.0, 42.3, 46.2, 48.3, 67.1,
82.5, 111.6, 128.0, 128.2, 128.3, 128.5, 141.1, 143.4, 155.4, 171.1.
HRMS: m/z [M + Na]+ calcd for C24H26N2NaO4S: 461.1511; found:
461.1516.
(9H-Fluoren-9-yl)methyl (S)-6-{[(Benzyloxy)carbonyl]amino}-
1-thiocyanatohexan-2-ylcarbamate [Fmoc-Lys(Z)-y(CH2SCN), 
2h]
Yield: 466 mg (88%); white solid; mp 106–108 °C; Rf = 0.30 (n-
hexane–EtOAc, 9:1).
IR (KBr): 1699, 2140 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.32–1.68 (m, 6 H), 3.02 (m, 2 H),
3.56 (d, J = 3.8 Hz, 2 H), 3.85 (m, 1 H), 4.12–4.35 (m, 3 H), 5.21 (s,
2 H), 6.43 (br, 2 H), 7.23–7.56 (m, 13 H).
13C NMR (100 MHz, CDCl3): d = 21.3, 29.6, 32.1, 38.6, 40.2, 47.2,
51.2, 62.2, 66.7, 112.3, 124.9, 127.0, 127.7, 128.0, 128.1, 128.5,
128.8, 136.5, 141.3, 143.7, 155.8, 156.6.
HRMS: m/z [M + NH4]+ calcd for C30H35N4O4S: 547.2379; found:
547.2373.
Methyl (R)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-3-
thiocyanatopropanoate [Fmoc-Ser(ySCN)-OMe, 2i]
Yield: 248 mg (65%); gum; Rf = 0.30 (n-hexane–EtOAc, 9:1).
IR (CH2Cl2): 1705, 1735, 2135 cm–1.
1H NMR (400 MHz, CDCl3): d = 3.59 (d, J = 4.4 Hz, 2 H), 3.82 (s,
3 H), 4.32 (t, J = 3.41 Hz, 1 H), 4.56 (d, J = 6.3 Hz, 2 H), 4.77 (m,
1 H), 5.97 (br, 1 H), 7.25–7.71 (m, 8 H).
13C NMR (100 MHz, CDCl3): d = 36.7, 47.7, 52.1, 53.1, 67.5,
112.1, 124.5, 125.6, 126.2, 127.1, 142.3, 144.9, 156.7, 171.9.
HRMS: m/z [M + Na]+ calcd for C20H18N2NaO4S: 405.0885; found:
405.0886.
Methyl (S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-4-
thiocyanatobutanoate [Fmoc-HSer(ySCN)-OMe, 2j]
Yield: 301 mg (76%); gum; Rf = 0.30 (n-hexane–EtOAc, 9:1).
IR (CH2Cl2): 1738, 2139 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.98–2.11 (m, 4 H), 3.02 (m, 1 H),
3.85 (s, 3 H), 4.05–4.32 (m, 3 H), 7.07–7.59 (m, 8 H), 7.61 (d,
J = 4.0 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = 21.4, 30.2, 47.6, 52.1, 53.0, 67.2,
112.8, 127.6, 127.7, 128.3, 129.4, 141.8, 144.2, 156.1, 171.1.
HRMS: m/z [M + NH4]+ calcd for C21H24N3O4S: 414.1488; found:
414.1484.
(9H-Fluoren-9-yl)methyl (S)-1-Selenocyanatopropan-2-ylcar-
bamate [Fmoc-Ala-y(CH2SeCN), 3a]
Yield: 343 mg (89%); white solid; mp 102–103 °C; Rf = 0.35 (n-
hexane–EtOAc, 9:1).
IR (KBr): 1698, 2145 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.21 (d, J = 5.2 Hz, 3 H), 3.25 (d,
J = 4.8 Hz, 2 H), 3.91 (m, 1 H), 4.11 (t, J = 4.2 Hz, 1 H), 4.23 (d,
J = 5.8 Hz, 2 H), 5.99 (d, J = 6.2 Hz, 1 H), 7.20–7.69 (m, 8 H).
13C NMR (100 MHz, CDCl3): d = 20.7, 33.8, 47.8, 48.9, 67.8,
101.9, 120.6, 125.6, 127.7, 128.3, 141.9, 144.3, 155.8.
HRMS: m/z [M + Na]+ calcd for C19H18N2NaO2Se: 409.0431;
found: 409.0438.
(9H-Fluoren-9-yl)methyl (S)-3-Methyl-1-selenocyanatobutan-
2-ylcarbamate [Fmoc-Val-y(CH2SeCN), 3b]
Yield: 364 mg (88%); white solid; mp 109–110 °C; Rf = 0.30 (n-
hexane–EtOAc, 9:1).
IR (KBr): 1699, 2144 cm–1.
1H NMR (400 MHz, CDCl3): d = 0.92 (d, J = 6.6 Hz, 6 H), 1.84 (m,
1 H), 3.17 (d, J = 4.8 Hz, 2 H), 3.67 (m, 1 H), 4.39 (t, J = 4.4 Hz, 1
H), 4.48 (d, J = 5.4 Hz, 2 H), 4.85 (d, J = 5.6 Hz, 1 H), 7.26–7.73
(m, 8 H).
13C NMR (100 MHz, CDCl3): d = 18.7, 19.9, 32.3, 33.2, 47.8, 57.2,
67.1, 102.6, 120.5, 127.6, 128.3, 141.9, 144.2, 156.7.
HRMS: m/z [M + Na]+ calcd for C21H22N2NaO2Se: 437.0744;
found: 437.0750.
(9H-Fluoren-9-yl)methyl (S)-4-Methyl-1-selenocyanatopentan-
2-ylcarbamate [Fmoc-Leu-y(CH2SeCN), 3c]
Yield: 368 mg (86%); white solid; mp 111–113 °C; Rf = 0.30 (n-
hexane–EtOAc, 9:1).
IR (KBr): 1701, 2141 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.03 (m, 6 H), 1.31 (m, 2 H), 1.93
(m, 1 H), 3.12 (d, J = 5.9 Hz, 2 H), 3.95 (m, 1 H), 4.21–4.31 (m, 3
H), 6.53 (br, 1 H), 7.21–7.67 (m, 8 H).
13C NMR (100 MHz, CDCl3): d = 21.6, 22.9, 24.9, 33.5, 43.8, 47.8,
51.0, 67.2, 102.7, 121.0, 125.5, 127.6, 128.4, 141.8, 144.5, 157.5.
HRMS: m/z [M + Na]+ calcd for C22H24N2NaO2Se: 451.0901;
found: 451.0908.
Methyl (S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-5-
selenocyanatopentanoate (3d)
Yield: 407 mg (89%); gum; Rf = 0.32 (n-hexane–EtOAc, 9:1).
IR (CH2Cl2): 1712, 1742, 2146 cm–1.
1H NMR (400 MHz, CDCl3): d = 1.52 (m, 2 H), 1.85 (m, 2 H), 2.21
(t, J = 3.4 Hz, 2 H), 3.65 (s, 3 H), 4.18 (m, 1 H), 4.38 (t, J = 4.2 Hz,
1 H), 4.59 (d, J = 4.8 Hz, 2 H), 5.42 (br, 1 H), 7.18–7.72 (m, 8 H).
13C NMR (100 MHz, CDCl3): d = 21.0, 27.6, 34.1, 46.7, 51.6, 55.0,
67.0, 102.1, 122.1, 125.7, 127.7, 128.3, 141.9, 144.3, 156.0, 172.0.
HRMS: m/z [M + Na]+ calcd for C22H22N2NaO4Se: 481.0642;
found: 481.0649.
Methyl (R)-2-Amino-3-thiocyanatopropanoate [H-Ser(ySCN)-
OMe, 4i]
Yield: 57 mg (98% from 2i); gum.
IR (CH2Cl2): 1735, 2135 cm–1.
1H NMR (400 MHz, DMSO-d6): d = 3.48 (d, J = 5.0 Hz, 2 H), 3.82
(s, 3 H), 4.07 (m, 1 H), 5.01 (br, 2 H).
13C NMR (100 MHz, DMSO-d6): d = 35.8, 52.1, 53.5, 112.1, 171.5.
ESI-MS: m/z [M – H]+ calcd for C5H7N2O2S: 159.02; found:
159.06.
Methyl (S)-2-Amino-5-selenocyanatopentanoate (5d)
Yield: 63 mg (95% from 3d); gum.
IR (CH2Cl2): 1742, 2146 cm–1.
1H NMR (400 MHz, DMSO-d6): d = 1.22 (m, 2 H), 1.55 (m, 2 H),
2.55 (t, J = 3.8 Hz, 2 H), 3.59 (s, 3 H), 3.68 (m, 1 H), 5.21 (br, 2 H).
13C NMR (100 MHz, DMSO-d6): d = 21.2, 28.5, 33.9, 51.5, 53.5,
102.1, 171.8.
ESI-MS: m/z [M – H]+ calcd for C7H11N2O2Se: 234.99; found:
235.00.
(R)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-3-thiocy-
anatopropanoic Acid [Fmoc-Ser(ySCN)-OH, 6i]
Yield: 57 mg (85% from 2i); gum; Rf = 0.20 (CHCl3–MeOH, 8:2).
IR (CH2Cl2): 1705, 2138 cm–1.
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1H NMR (400 MHz, DMSO-d6): d = 3.39 (d, J = 4.6 Hz, 2 H), 4.27
(t, J = 3.8 Hz, 1 H), 4.37 (m, 1 H), 4.66 (d, J = 6.4 Hz, 2 H), 6.12
(br, 1 H), 7.25–7.71 (m, 8 H), 10.98 (br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 35.8, 47.5, 53.5, 67.1, 111.9,
124.6, 125.8, 126.6, 127.5, 141.5, 144.5, 155.9, 172.1.
HRMS: m/z [M + Na]+ calcd for C19H16N2NaO4S: 391.0728; found:
391.0734.
(S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-5-seleno-
cyanatopentanoic Acid (7d)
Yield: 68 mg (75% from 3d); gum; Rf = 0.20 (CHCl3–MeOH, 8:2).
IR (CH2Cl2): 1712, 2140 cm–1.
1H NMR (400 MHz, DMSO-d6): d = 1.32 (m, 2 H), 1.45 (m, 2 H),
2.11 (t, J = 4.0 Hz, 2 H), 3.95 (m, 1 H), 4.38 (t, J = 4.4 Hz, 1 H),
4.59 (d, J = 5.0 Hz, 2 H), 6.82 (br, 1 H), 7.18–7.72 (m, 8 H), 10.99
(br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 21.3, 28.1, 33.8, 46.5, 54.8,
67.1, 101.5, 122.3, 125.5, 127.8, 128.5, 141.5, 144.7, 156.5, 172.7.
HRMS: m/z [M + Na]+ calcd for C21H20N2NaO4Se: 467.0486;
found: 467.0481.
N-Fmoc Amino Alkyl S/Se-Linked Tetrazoles 8/9; General Pro-
cedure
A mixture of a N-Fmoc amino alkyl thiocyanate/selenocyanate 2/3
(1 mmol), NaN3 (162 mg, 2.5 mmol) and ZnBr2 (222 mg, 1 mmol)
in i-PrOH–H2O (1:1, 30 mL) was heated to reflux for 4–5 h with
stirring. After cooling, the reaction mixture was acidified with 10%
HCl and diluted with EtOAc (15 mL). The aqueous layer was ex-
tracted with EtOAc (2 × 5 mL). The combined organic layer was
washed with H2O (2 × 10 mL) and brine (10 mL), and dried (anhyd
Na2SO4). The solvent was removed under reduced pressure and the
residue was either recrystallized (THF–hexane, 1:4) or column
chromatographed.
(9H-Fluoren-9-yl)methyl (S)-1-(2H-Tetrazol-5-ylthio)propan-
2-ylcarbamate [Fmoc-Ala-y(CH2SCN4H), 8a]
Yield: 351 mg (92%); white solid; mp 92–94 °C; Rf = 0.2 (CHCl3–
MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 1.19 (d, J = 6.4 Hz, 3 H), 3.49
(d, J = 4.6 Hz, 2 H), 3.83 (m, 1 H), 4.18 (t, J = 5.4 Hz, 1 H), 4.27 (d,
J = 7.2 Hz, 2 H), 6.70 (br, 1 H), 7.29–7.88 (m, 9 H).
13C NMR (100 MHz, DMSO-d6): d = 19.8, 37.8, 46.2, 46.7, 66.9,
120.1, 125.1, 126.9, 127.5, 140.7, 143.8, 154.2, 155.5.
ESI-MS: m/z [M + H]+ calcd for C19H20N5O2S: 382.13; found:
382.05.
(9H-Fluoren-9-yl)methyl (S)-3-Methyl-1-(2H-tetrazol-5-yl-
thio)butan-2-ylcarbamate [Fmoc-Val-y(CH2SCN4H), 8b]
Yield: 356 mg (87%); gum; Rf = 0.3 (CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 0.87 (d, J = 5.8 Hz, 6 H), 2.32
(m, 1 H), 3.32 (d, J = 4.7 Hz, 2 H), 3.85 (m, 1 H), 3.96 (t, J = 5.2
Hz, 1 H), 4.07 (d, J = 7.1 Hz, 2 H), 6.96 (br, 1 H), 7.32–7.70 (m, 8
H), 7.98 (br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 18.0, 18.9, 32.2, 36.9, 46.7,
56.2, 65.2, 120.0, 125.1, 126.9, 127.5, 140.7, 143.7, 154.8, 156.0.
HRMS: m/z [M + H]+ calcd for C21H24N5O2S: 410.1651; found:
410.1646.
(9H-Fluoren-9-yl)methyl (S)-3-Phenyl-1-(2H-tetrazol-5-yl-
thio)propan-2-ylcarbamate [Fmoc-Phe-y(CH2SCN4H), 8c]
Yield: 403 mg (88%); white solid; mp 141–142 °C; Rf = 0.22
(CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 2.69 (d, J = 6.2 Hz, 2 H), 3.39
(d, J = 5.7 Hz, 2 H), 4.18 (t, J = 4.3 Hz, 1 H), 4.28 (d, J = 5.0 Hz, 2
H), 4.89 (m, 1 H), 6.48–6.71 (br, 1 H), 7.23–7.49 (m, 13 H), 7.67
(m, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 37.8, 39.5, 46.7, 51.9, 65.6,
125.2, 126.2, 127.1, 127.6, 128.2, 128.6, 129.2, 138.2, 140.7, 143.8,
155.6, 172.0.
HRMS: m/z [M + Na]+ calcd for C25H23N5NaO2S: 480.1470; found:
480.1465.
(9H-Fluoren-9-yl)methyl (S)-1-Phenyl-1-(2H-tetrazol-5-yl-
thio)ethylcarbamate [Fmoc-Phg-y(CH2SCN4H), 8d]
Yield: 403 mg (88%); white solid; mp 151–152 °C; Rf = 0.20
(CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 3.52 (d, J = 4.8 Hz, 2 H), 4.12
(t, J = 3.8 Hz, 1 H), 4.26 (d, J = 6.4 Hz, 2 H), 4.82 (m, 1 H), 5.92
(br, 1 H), 7.26–7.68 (m, 13 H), 8.21 (br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 37.7, 46.7, 54.2, 65.4, 120.1,
125.1, 126.3, 127.0, 127.6, 128.5, 140.7, 141.5, 143.7, 155.7, 156.8.
HRMS: m/z [M + H]+ calcd for C24H22N5O2S: 444.1494; found:
444.1498.
(9H-Fluoren-9-yl)methyl (S)-2-[(2H-Tetrazol-5-ylthio)meth-
yl]pyrrolidine-1-carboxylate [Fmoc-Pro-y(CH2SCN4H), 8e]
Yield: 346 mg (85%); gum; Rf = 0.20 (CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 1.61–1.72 (m, 4 H), 3.31 (m,
2 H), 3.61 (m, 2 H), 3.80 (m, 1 H), 4.11 (t, J = 4.3 Hz, 1 H), 4.32 (d,
J = 5.7 Hz, 2 H), 7.30–7.81 (m, 9 H).
13C NMR (100 MHz, DMSO-d6): d = 22.2, 29.4, 37.5, 45.0, 47.1,
51.6, 66.7, 125.0, 126.1, 127.0, 128.8, 140.3, 143.1, 155.1, 156.2.
HRMS: m/z [M + H]+ calcd for C21H22N5O2S: 408.1494; found:
408.1495.
(9H-Fluoren-9-yl)methyl (S)-1-(Benzylthio)-3-(2H-tetrazol-5-
ylthio)propan-2-ylcarbamate [Fmoc-Cys(Bn)-y(CH2SCN4H), 
8f]
Yield: 428 mg (85%); white solid; mp 142–143 °C; Rf = 0.25
(CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 2.13 (d, J = 4.9 Hz, 2 H), 3.35
(d, J = 6.4 Hz, 2 H), 3.75 (s, 2 H), 4.11–4.31 (m, 3 H), 4.45 (m, 1
H), 5.31 (br, 1 H), 7.19–7.80 (m, 14 H).
13C NMR (100 MHz, DMSO-d6): d = 35.1, 36.0, 41.0, 46.7, 50.0,
65.5, 125.2, 126.9, 127.1, 127.6, 128.4, 128.9, 130.3, 138.3, 140.7,
143.8, 155.1, 156.3.
HRMS: m/z [M + NH4]+ calcd for C26H29N6O2S2: 521.1793; found:
521.1785.
tert-Butyl (S)-3-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-
4-(2H-tetrazol-5-ylthio)butanoate [Fmoc-Asp(t-Bu)-
y(CH2SCN4H), 8g]
Yield: 376 mg (78%); white solid; mp 78–80 °C; Rf = 0.20 (CHCl3–
MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 1.34 (s, 9 H), 2.52 (d, J = 5.2
Hz, 2 H), 3.41 (m, 2 H), 4.11 (m, 1 H), 4.20 (t, J = 4.1 Hz, 1 H), 4.28
(d, J = 5.6 Hz, 2 H), 7.28–7.88 (m, 10 H).
13C NMR (100 MHz, DMSO-d6): d = 27.6, 36.5, 43.6, 46.6, 47.7,
65.4, 80.1, 120.0, 125.0, 127.0, 127.5, 140.7, 143.7, 155.4, 156.6,
169.3.
HRMS: m/z [M + Na]+ calcd for C24H27N5NaO4S: 504.1681; found:
504.1686.
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(9H-Fluoren-9-yl)methyl (S)-6-{[(Benzyloxy)carbonyl]amino}-
1-(2H-tetrazol-5-ylthio)hexan-2-ylcarbamate [Fmoc-Lys(Z)-
y(CH2SCN4H), 8h]
Yield: 447 mg (78%); white solid; mp 148–150 °C; Rf = 0.20
(CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 1.27–1.41 (m, 6 H), 2.66–2.81
(m, 2 H), 2.97 (d, J = 4.2 Hz, 2 H), 3.73 (br, 1 H), 4.20–4.31 (m, 3
H), 5.00 (s, 2 H), 7.29–7.51 (m, 13 H), 7.68 (s, 1 H), 7.88 (d, J = 5.7
Hz, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 22.7, 29.1, 33.2, 37.1, 42.7,
46.7, 50.3, 65.1, 65.2, 120.0, 125.1, 127.0, 127.6, 127.8, 128.3,
137.2, 140.7, 143.7, 154.3, 155.9, 156.0.
HRMS: m/z [M + H]+ calcd for C30H33N6O4S: 573.2284; found:
573.2287.
Methyl (R)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-3-
(2H-tetrazol-5-ylthio)propanoate [Fmoc-Ser(ySCN4H)-OMe, 
8i]
Yield: 276 mg (65%); gum; Rf = 0.30 (CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 3.62 (d, J = 5.6 Hz, 2 H), 3.84
(s, 3 H), 4.21 (t, J = 4.7 Hz, 1 H), 4.42 (d, J = 6.4 Hz, 2 H), 4.82 (m,
1 H), 6.92 (br, 1 H), 7.31–7.71 (m, 8 H), 8.01 (br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 33.8, 47.5, 52.9, 53.5, 67.5,
123.2, 125.2, 126.4, 127.1, 140.9, 143.1, 154.3, 157.1, 171.3.
HRMS: m/z [M + H]+ calcd for C20H20N5O4S: 426.1236; found:
426.1232.
Methyl (S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-4-
(2H-tetrazol-5-ylthio)butanoate [Fmoc-HSer(ySCN4H)-OMe, 
8j]
Yield: 334 mg (76%); gum; Rf = 0.25 (CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 2.03 (m, 2 H), 3.31 (t, J = 3.6
Hz, 2 H), 3.75 (s, 3 H), 4.01 (m, 1 H), 4.15–4.29 (m, 3 H), 6.15 (br,
1 H), 7.12–7.62 (m, 9 H).
13C NMR (100 MHz, DMSO-d6): d = 31.0, 35.1, 47.3, 52.2, 57.0,
66.9, 125.2, 126.5, 127.1, 128.0, 141.1, 144.3, 154.1, 156.0, 176.0.
HRMS: m/z [M + Na]+ calcd for C21H21N5NaO4S: 462.1212; found:
462.1217.
(9H-Fluoren-9-yl)methyl (S)-1-(2H-Tetrazol-5-ylselanyl)pro-
pan-2-ylcarbamate [Fmoc-Ala-y(CH2SeCN4H), 9a]
Yield: 381 mg (89%); white solid; mp 136–139 °C; Rf = 0.25
(CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 1.27 (d, J = 6.7 Hz, 3 H), 3.43
(d, J = 6.4 Hz, 2 H), 3.81 (m, 1 H), 4.11 (t, J = 3.4 Hz, 1 H), 4.28 (d,
J = 5.7 Hz, 2 H), 5.08 (br, 1 H), 7.25–7.90 (m, 9 H).
13C NMR (100 MHz, DMSO-d6): d = 21.3, 34.7, 47.6, 47.8, 66.2,
121.0, 126.1, 127.9, 128.5, 141.6, 144.8, 154.0, 156.4.
HRMS: m/z [M + H]+ calcd for C19H20N5O2Se: 430.0782; found:
430.0790.
(9H-Fluoren-9-yl)methyl (S)-3-Methyl-1-(2H-tetrazol-5-ylsela-
nyl)butan-2-ylcarbamate [Fmoc-Val-y(CH2SeCN4H), 9b]
Yield: 392 mg (86%); gum; Rf = 0.24 (CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 0.85 (d, J = 6.5 Hz, 6 H), 1.81
(d, J = 5.6 Hz, 1 H), 3.38 (d, J = 5.4 Hz, 2 H), 3.93 (m, 1 H), 4.30
(t, J = 4.0 Hz, 1 H), 4.42 (d, J = 5.5 Hz, 2 H), 5.75 (m, 1 H), 7.31–
7.99 (m, 9 H).
13C NMR (100 MHz, DMSO-d6): d = 18.2, 19.1, 30.5, 32.8, 46.7,
53.1, 66.9, 120.0, 125.1, 126.9, 127.5, 140.6, 143.5, 154.9, 156.0.
HRMS: m/z [M + Na]+ calcd for C21H23N5NaO2Se: 480.0915;
found: 480.0923.
(9H-Fluoren-9-yl)methyl (S)-4-Methyl-1-(2H-tetrazol-5-ylsela-
nyl)pentan-2-ylcarbamate [Fmoc-Leu-y(CH2SeCN4H), 9c]
Yield: 399 mg (85%); gum; Rf = 0.25 (CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 0.82 (m, 6 H), 1.21 (m, 2 H),
1.87 (m, 1 H), 3.41 (d, J = 6.4 Hz, 2 H), 3.79 (m, 1 H), 4.11 (t,
J = 4.4 Hz, 1 H), 4.24 (d, J = 5.1 Hz, 2 H), 6.29 (br, 1 H), 7.20–7.98
(m, 9 H).
13C NMR (100 MHz, DMSO-d6): d = 22.7, 24.0, 25.4, 34.4, 44.2,
47.7, 49.9, 66.0, 121.0, 126.1, 128.0, 128.5, 141.7, 144.8, 156.7,
166.9.
HRMS: m/z  [M + H]+ calcd for C22H26N5O2Se: 472.1252; found:
472.1260.
Methyl (S)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-5-
(2H-tetrazol-5-ylselanyl)pentanoate (9d)
Yield: 395 mg (79%); gum; Rf = 0.25 (CHCl3–MeOH, 8:2).
1H NMR (400 MHz, DMSO-d6): d = 1.32 (m, 2 H), 1.71 (m, 2 H),
2.05 (t, J = 3.6 Hz, 2 H), 3.55 (s, 3 H), 3.95 (m, 1 H), 4.19 (t, J = 4.2
Hz, 1 H), 4.30 (d, J = 5.2 Hz, 2 H), 6.20 (br, 1 H), 7.26–7.90 (m, 9
H).
13C NMR (100 MHz, DMSO-d6): d = 22.5, 29.1, 33.3, 47.5, 51.2,
54.2, 66.5, 124.0, 125.1, 127.0, 128.2, 141.0, 144.1, 154.9, 156.0,
171.0.
HRMS: m/z [M + Na]+ calcd for C22H23N5NaO4Se: 524.0813;
found: 524.0818.
(S)-1-(2H-Tetrazol-5-ylthio)propan-2-amine [H-Ala-
y(CH2SCN4H), 10a]
Yield: 54 mg (97% from 8a); pale yellow solid; mp 178–180 °C.
1H NMR (400 MHz, DMSO-d6): d = 1.22 (d, J = 6.2 Hz, 3 H), 3.13
(m, 1 H), 3.31 (d, J = 4.4 Hz, 2 H), 5.12 (br, 2 H), 7.54 (br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 19.5, 38.5, 47.8, 155.9.
ESI-MS: m/z [M – H]+ calcd for C4H8N5S: 158.05; found: 158.09.
(S)-5-[(Pyrrolidin-2-ylmethyl)thio]-2H-tetrazole [H-Pro-
y(CH2SCN4H), 10e]
Yield: 61 mg (92% from 8e); gum.
1H NMR (400 MHz, DMSO-d6): d = 1.50–1.69 (m, 4 H), 2.99 (m,
2 H), 3.20 (m, 1 H), 3.41 (d, J = 5.4 Hz, 2 H), 5.01 (m, 1 H), 7.68
(br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 23.5, 32.4, 38.2, 45.3, 51.6,
154.9.
ESI-MS: m/z [M – H]+ calcd for C6H10N5S: 184.06; found: 184.08.
(S)-3-Methyl-1-(2H-tetrazol-5-ylselanyl)butan-2-amine [H-Val-
y(CH2SeCN4H), 11b]
Yield: 55 mg (96% from 9b); pale yellow solid; mp 186–187 °C.
1H NMR (400 MHz, DMSO-d6): d = 0.99 (d, J = 6.2 Hz, 6 H), 1.85
(d, J = 5.8 Hz, 1 H), 3.88 (d, J = 5.6 Hz, 2 H), 4.21 (m, 1 H), 5.91
(br, 2 H), 7.91 (br, 1 H).
13C NMR (100 MHz, DMSO-d6): d = 18.1, 32.5, 35.9, 53.5, 155.1.
ESI-MS: m/z [M – H]+ calcd for C6H12N5Se: 234.02; found: 234.03.
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